Skip to main content

Special Issues

Best Practices in Ovarian Function Suppression in Breast Cancer
Read More
Faculty Perspectives: Comprehensive Biomarker Testing in NSCLC: Opportunities to Advance Precision Medicine
Read More
2022 Year in Review - Multiple Myeloma
Read More
2022 Year in Review - Cholangiocarcinoma
Read More
August 2022 Clinical Trials to Clinical Practice
Read More
Lung Cancer
2022 Midyear Review: Non–Small-Cell Lung Cancer
Read More
Faculty Perspectives: Through the Pharmacists’ Lens: A Deep Dive into the Practice Dynamics in Graft-versus-Host Disease
Read More
First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma
Read More
Chronic Lymphocytic Leukemia
Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days
Read More
First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma
Read More
Page 2 of 6
Results 11 - 20 of 59